Reduction of inflammatory complications in meningitis and some pericarditis
Public health rationale
Treatment reduces transmission risk
Contact tracing interrupts spread
Patient Discharge Instructions
copy discharge instructions
Discharge instructions for suspected or confirmed TB
Infection control at home
Mask when around others until cleared by TB program
Stay in a separate room when possible
Improve ventilation by opening windows when safe
Avoid visitors and crowded indoor places
Medication adherence
Do not miss doses
Do not stop meds without TB clinician direction
Take pyridoxine if prescribed with isoniazid
Expected side effects requiring urgent contact
Yellow skin or eyes
Dark urine
Severe abdominal pain
Persistent vomiting
New severe rash
Vision changes
Severe weakness or numbness
Emergency return now
Trouble breathing
Chest pain
Fainting
Coughing up large amounts of blood
Severe headache or confusion
New seizures
Follow up plan
TB clinic or infectious diseases appointment date and location
Public health contact expected for questions and contact tracing
Avoid work or school until cleared by TB program
References
Clinical guidelines and key sources
Guideline sources
World Health Organization consolidated guidelines on tuberculosis
Active TB treatment recommendations
LTBI treatment recommendations
CDC tuberculosis clinical guidance
Diagnostic testing and NAAT use
LTBI regimens
ATS IDSA CDC clinical practice guidelines for drug susceptible TB
Standard RIPE regimen and duration
National and provincial public health TB standards
Reporting requirements
Isolation discontinuation criteria
Pediatric TB guidance
Weight based dosing and severe TB forms
SymptomDx is an educational tool for medical professionals. It does not replace clinical judgment. Verify all clinical data and drug dosages with authoritative sources.